BRD2 Antikörper (intact)

Produktnummer ABIN235189

Produktdetails anti-BRD2 Antikörper

Target: BRD2 (Bromodomain Containing 2 (BRD2))

Bindungsspezifität: intact

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser BRD2 Antikörper ist unkonjugiert

Applikation: ELISA, Radioimmunoassay (RIA), Protein Assay (PrA)

Spezifität: Recognizes the c1 epitope, a conformational epitope which is only detectable when the alpha and beta subunits of FSH are associated (intact FSH). No cross-reaction is detected in RIA with human FSH beta or any other human glycoprotein hormone or subunit thereof. Two-site sandwich ELISA revealed recognition of a conformational epitope on intact human FSH which is located near the alpha 1, alpha 2 and alpha 4 epitopes.

Produktmerkmale: MAb to Human FSH (intact), Monoclonal antibody to Human Follicle Stimulating Hormone (FSH) intact, cl epitope, Tissue culture Hybridization of X63-Ag8.653 myeloma cells.

Aufreinigung: Protein A Chromatography. Tissue culture

Reinheit: > 95 % pure (SDS PAGE)

Immunogen: Human FSH

Klon: INN-hFSH-117

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Suitable for use in ELISA and Radioimmunoassay.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Hanks balanced salt solution, 0.09 % Sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid multiple freeze/thaw cycles.
Centrifuge product if not completely clear after standing at room temperature.
Prepare working dilution only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Short-term (up to 1 month) store at 2-8 °C. Long term, aliquot and store at -28 °C.

Haltbarkeit: 1 month

Details zu BRD2

Target: BRD2 (Bromodomain Containing 2 (BRD2))

Andere Bezeichnung: Follie Stimulating Hormone (FSH) (BRD2 Produkte)

Synonyme: D6S113E antikoerper, FSH antikoerper, FSRG1 antikoerper, NAT antikoerper, RING3 antikoerper, RNF3 antikoerper, AW228947 antikoerper, D17H6S113E antikoerper, Frg-1 antikoerper, Fsrg-1 antikoerper, Fsrg1 antikoerper, Nat antikoerper, Ring3 antikoerper, Rnf3 antikoerper, mKIAA4005 antikoerper, brd2-a antikoerper, fsh antikoerper, fsrg1 antikoerper, nat antikoerper, ring3 antikoerper, rnf3 antikoerper, brd2 antikoerper, fe47f02 antikoerper, fi85h05 antikoerper, wu:fe47f02 antikoerper, wu:fi85h05 antikoerper, Ring3 protein antikoerper, bromodomain containing 2 antikoerper, bromodomain containing 2 S homeolog antikoerper, bromodomain containing 2a antikoerper, CHLREDRAFT_190116 antikoerper, CHLREDRAFT_150233 antikoerper, CHLREDRAFT_182576 antikoerper, CHLREDRAFT_188250 antikoerper, BRD2 antikoerper, Brd2 antikoerper, brd2.S antikoerper, brd2a antikoerper

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion